Only 50ml of urine can complete the bladder cancer detection, no trauma, no pain, and the test can be done anytime. On August 4, Hainan Cancer Hospital was the first in the province to launch the “DNA methylation bladder cancer detection” service.
Bladder cancer is a relatively common malignant tumor, accounting for the highest incidence of male genitourinary tumors in my country. It has the characteristics of high postoperative recurrence rate and high mortality rate.
In the early stage of bladder cancer, there are no obvious symptoms, so it is not easy to detect. When symptoms such as blood in the urine appear, the disease may have developed to the middle and late stages, and the best time for treatment is lost.
Early detection, early diagnosis and early treatment are the most effective means to curb the occurrence of bladder cancer.
Qu Jun, deputy director of the Department of Urology of Hainan Cancer Hospital, said that early bladder cancer has a high cure rate through active and effective treatment. However, when lymph node metastasis or systemic spread occurs in the middle and late stages, it is not only difficult to treat, but also prone to recurrence and high treatment costs. , the survival time and quality of life of patients are also greatly reduced. Therefore, it is very necessary to carry out early accurate screening of bladder cancer.
Currently, cystoscopy + pathological biopsy is the “gold standard” for diagnosing bladder cancer. However, due to the complex structure of the male urethra, cystoscopy may rub or damage the urethra, causing pain and discomfort to patients. Many patients are afraid of pain. And delay, refusal to check, resulting in delays in the disease.
Xu Xianhua, director of the Department of Pathology, Hainan Cancer Hospital, said that “DNA methylation bladder cancer detection” is a non-invasive detection technology that can diagnose bladder cancer by detecting DNA methylation substances in patients’ urine Happening. Compared with traditional cystoscopy, it has the advantages of convenient, fast, non-invasive and painless examination.
It is worth mentioning that the DNA methylation bladder cancer detection technology has a high accuracy rate. It can not only accurately detect early and small bladder tumors, but also monitor the recurrence of bladder cancer after surgery.
Qu Jun said that after the early stage bladder cancer is treated by endoscopic surgery, continuous review and routine cystoscopy are required, which is very painful for the patient. The detection of DNA methylation bladder cancer is convenient, painless, and easier for patients to accept.
Qu Jun reminded that bladder cancer mostly occurs in men over the age of 50, and the incidence is related to a variety of factors, including family history of bladder cancer, long-term smoking or occupational exposure, such as exposure to aromatic amine chemicals and dyes. It is recommended that high-risk groups “check in” on time every year for urinary system examinations to exclude hidden cancer risks. (Text: Chen Lin, Hainan Cancer Hospital)